BridgeMD
New treatment option for Duration of Labor
Official title Effects of Midwife-guided biırth Affirmation Cards on Labor Process and Experience ın Primigravidas
ClinicalTrials.gov ID: NCT07542392
What this study is testing
- What it's testing
- The aim of this study is to evaluate the effects of midwife-guided birth affirmation cards on labor duration, pain level, fear of childbirth, perceived control, and perceived support in primigravidas. The study seeks to determine whether this non-pharmacological approach used during labor improves the childbirth experience.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 40, women only. Healthy volunteers may be eligible.
You may be able to join if
- Having a singleton pregnancy between 37-42 weeks of gestation
- Being between 18-40 years of age
- Being a primigravida
- Having a cephalic presentation with vertex position
- Being in the active phase of labor (cervical dilatation ≥4 cm)
You likely can't join if
- High-risk pregnancies
- Pregnant women at risk of intrapartum complications (e.g., oligohydramnios, polyhydramnios, intrauterine fetal demise, placenta previa, placental...
- Pregnant women with a history of medical or obstetric complications
- Women who have attended antenatal education classes (pregnancy school)
- Women using epidural analgesia or other pharmacological pain management methods
- Women experiencing communication difficulties
See the full eligibility criteria
- Having a singleton pregnancy between 37-42 weeks of gestation
- Being between 18-40 years of age
- Being a primigravida
- Having a cephalic presentation with vertex position
- Being in the active phase of labor (cervical dilatation ≥4 cm)
- Accepting non-invasive interventions
- Having no mental or physical disability
- Being able to understand and speak Turkish
- Willingness to participate in the study
- High-risk pregnancies
- Pregnant women at risk of intrapartum complications (e.g., oligohydramnios, polyhydramnios, intrauterine fetal demise, placenta previa, placental abruption, acute fetal distress, preeclampsia, fetal dystocia...
- Pregnant women with a history of medical or obstetric complications
- Women who have attended antenatal education classes (pregnancy school)
- Women using epidural analgesia or other pharmacological pain management methods
- Women experiencing communication difficulties
- Women who are unwilling to participate in the study Exclusion Criteria from the Study
- Experiencing dizziness, shortness of breath, or other discomfort,
- Difficult and prolonged labor, instrumental delivery, placental retention, postpartum hemorrhage, need for neonatal intensive care,
- Situations requiring emergency cesarean section during labor,
- The woman will be excluded from the study if she ceases to cooperate during labor.
The study team makes the final eligibility decision.
Where it's taking place
- Mut, Mersi̇n, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 40 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Mut, Mersi̇n, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.